January 7, 2011 ·
Leave a comment
Prateek Peres-da-Silva, an intern at Thought Leader Select and student at the University of North Carolina’s Kenan-Flagler Business School, recently sat down with Dr. Maher “Max” Noureddine, Thought Leader Select’s departing chief scientific officer, to discuss his achievements at the company, as well as his vision for the non-profit he is launching to improve the professional lives of health care providers. Peres-da-Silva is a junior at UNC, double-majoring in business and biochemistry.
Prateek Peres-da-Silva: In part one of the interview, we talked about your work for Thought Leader Select. For the rest of our conversation, I’d like to hear your take on the future. What are your plans for the new year?
Max Noureddine: I stepped down from my position with Thought Leader Select to focus completely on establishing and running a new non-profit entity, which I have named The Institute for Advanced Career Development (IACD).
Prateek Peres-da-Silva: In some of our previous conversations, you have mentioned that there will be several mentoring programs, aimed at educating healthcare and legal professionals, set up under the institute’s umbrella. Can you tell us more about these programs?
Max Noureddine: One of the immediate objectives of the IACD is to provide healthcare professionals and scientific researchers with training and mentorship on how to shape their careers to become effective leaders in their areas of specialty. The sustained, ... read more »
TAGS: 
career development DNA forensics Healthcare Professionals Institute for Advanced Career Development Kenan-Flagler Business School legal professionals Maher Noureddine mentoring Prateek Peres-da-Sliva scientific researchers Thought Leader Select University of North Carolina at Chapel Hill
December 30, 2010 ·
Leave a comment
Prateek Peres-da-Silva, an intern at Thought Leader Select and student at the University of North Carolina’s Kenan-Flagler Business School, recently sat down with Dr. Maher “Max” Noureddine, Thought Leader Select’s departing chief scientific officer, to discuss his achievements at the company, as well as his vision for the non-profit he is launching to improve the professional lives of health care providers. Peres-da-Silva is a junior at UNC, double-majoring in business and biochemistry.
Prateek Peres-da-Silva: Good morning, Max. I’d like to hear some of your thoughts on your time at Thought Leader Select. Can you share a little about yourself and your role with the company?
Max Noureddine: Yes, Prateek. In terms of my training, I am a molecular geneticist with experience in biomedical research. I did my doctoral training in the genetics of cell cycle regulation, and then focused on the molecular genetics of neurodegenerative disorders as well as cancer. I joined Thought Leader Select in the fall of 2007 as the chief scientific officer and director of product development. In collaboration with an outstanding team at the company, I became responsible for the development and execution of the company’s line of competitive services and solutions in the area of key opinion leader assessments and profiling in particular, and in pharmaceutical consulting in general. As CSO, I am responsible for validating the ... read more »
TAGS: biomedical research biopharmaceutical biotechnology cancer cell cycle regulation health care providers impact mapping Kenan-Flagler Business School key opinion leaders KOL engagement KOL identification KOL profiling KOLs Maher Noureddine molecular genetics neurodegenerative disorders pharmaceutical Prateek Peres-da-Silva product development Thought Leader Index Thought Leader Select Thought Leader Select Innovation Lab UNC value mapping
December 23, 2010 ·
Leave a comment
Press Release Out Today from the Offices of Thought Leader Select
December 23, 2010 (CHAPEL HILL, NC)—Dr. Maher “Max” Noureddine, a noted Parkinson’s disease researcher and chief scientific officer at North Carolina-based research firm Thought Leader Select, is leaving the company to launch the Institute for Advanced Career Development (IACD) on January 3, 2011.
The institute will offer an array of programs for medical professionals seeking to advance their academic careers in their respective medical fields. Programs on offer will include a physician-centric curriculum called MedMentors, courses for nurses called RNMentors, and courses for pharmacists and veterinarians called PharMentors and VetMentors, respectively.
In addition to the programs centered on leadership in allied health professions, Dr. Noureddine will lead development courses for legal professionals interested in understanding the science of DNA-based evidence. Dr. Noureddine is trained in human molecular genetics with years of laboratory research experience at top institutions such as UNC-Chapel Hill, Duke Medical Center, and The National Institutes of Health.
“I am excited to take all of my scientific training and combine it with my experience in working directly with leading academic medical specialists from across the globe,” stated Noureddine. “While I am sad to be leaving Thought Leader Select, I am doing so with the company’s complete endorsement—they really believe in what I’m doing to advance scientific careers for better healthcare delivery. ... read more »
TAGS: allied health professionals biopharmaceutical DNA-based evidence Duke University Medical Cetner healthcare Institute for Advanced Career Development KOL engagement KOL identification KOL profiling Maher Noureddine medical professionals MedMentors National Institutes of Health nurses Paul Meade pharmacists physicians RNMentors Thought Leader Emerge Thought Leader Index Thought Leader Select University of North Carolina at Chapel Hill veterinarians
June 15, 2010 ·
Leave a comment
New press release out today from the offices of Thought Leader Select–
FOR IMMEDIATE RELEASE
June 14, 2010 (CHAPEL HILL, NC)—Thought Leader Select, a North Carolina company dedicated to delivering sophisticated solutions for key opinion leader relationship management in the pharmaceutical industry, announces the launch of its KOL Incubator.
The company, known for its proprietary deep profiling research methodology that promotes industry engagement with the right medical experts in an array of therapeutic areas and disease states, has complemented its web-based tool for identifying medical expert teams for a variety of drug development needs. The KOL Incubator tracks new and young physicians as they engage in breakthrough clinical research, publish in medical journals, and speak at scientific conferences.
The new engine will track the progress of these health care providers, known in the healthcare community as “rising stars,” as they advance medical science. The incubator will gauge the impact of their work at regional, national, and international levels as their landmark work defines treatment guidelines for the next generation of medicines for better public health outcomes.
As these budding key opinion leaders accumulate a body of work that proves their standing of respect within the medical community, Thought Leader Select will move them into their core database of the world’s top medical experts. “This is an ideal role for us to play in advancing the ... read more »
TAGS: advisory boards clinical research clinical trials continuing medical education deep-profiling disease states health care providers healthcare key opinion leaders KOL engagement KOL identification KOL Incubator KOL mapping KOL profiling Maher Noureddine medical experts medical journal publishing research methodology scientific conferences speakers bureaus therapeutic areas Thought Leader Select thought leaders
May 18, 2010 ·
Leave a comment
Clarissa Noureddine joined Thought Leader Select in 2007, after spending the previous four years as a practicing veterinarian. A graduate of the University of Florida, Clarissa earned a master’s degree in molecular biology from the University of North Carolina at Chapel Hill, followed by a doctor of veterinary medicine degree from North Carolina State University. In her role as senior research manager, Clarissa provides key insider perspectives on treatment, use of pharmacological agents, and the collaboration of doctors with the pharmaceutical industry to deliver thorough, accurate, and understandable key opinion leader identification and profiling research.
The Thought Leader Select Blog recently sat down to catch up with Clarissa Noureddine and learn about her background and how she makes her professional contribution to the work of Thought Leader Select.
TLS Blog: Good afternoon, Clarissa. Tell us why you joined Thought Leader Select.
Clarissa Noureddine: In 2006, I left veterinary practice to become a stay-at-home mom, as well as to pursue a much-needed change of scenery, professionally–one that would present new challenges on an ongoing basis. I immediately started doing research for Thought Leader Select and joined full-time as a research manager in March of 2007. In a very short period of time, I really came to love what I do—delivering key research on physicians to help drive better quality medications and higher standards of ... read more »
TAGS: Arabic belly dancing Clarissa Noureddine doctor of veterinary medicine key opinion leader KOL engagement KOL identification KOL mapping KOL profiling KOL research KOL selection Lebanon Maher Noureddine medical research molecular biology North Carolina State University public health senior research manager therapeutic area thought leader Thought Leader Select University of Florida University of North Carolina at Chapel Hill veterinarian
May 4, 2010 ·
Leave a comment
New press release out today from the offices of Thought Leader Select.
5/4/2010 (CHAPEL HILL, NC) Thought Leader Select, a North Carolina-based firm dedicated to delivering superior key opinion leader (KOL) management solutions to the biopharmaceutical industry, announces the completion of large speaker validation project for a top-20 US pharmaceutical company.
The pharmaceutical client contracted Thought Leader Select to validate the skills and experiences of a legion of health care professionals for the company’s speakers bureau. The firm asked Thought Leader Select to look at over 1,000 specialists, primary care physicians, nurses, pharmacists, and other important health care providers across several key dimensions, including: experience speaking within the medical community, clinical research involvement, publishing history, developing treatment guidelines, and active patient care.
Thought Leader Select’s validation process empowered the client with the knowledge that they were engaging experienced speakers with demonstrated experience in clinical practice, research, and speaking. The study’s findings also enabled the client company to determine fair market value (FMV) honoraria compensation for these health care providers.
“I thought it was only natural to ask Thought Leader Select to do this validation work for us,” stated the brand director for the client company. “They get so close to the data and have a real understanding of who these key opinion leaders are and why they are so important. Their methodology is so ... read more »
TAGS: biotechnology clinical research drug development health care professionals key opinion leader KOL KOL engagement KOL identification KOL management KOL profiling Maher Noureddine nurses patient care pharmaceutical pharmacists physicians publishing speaker validation speakers bureau Thought Leader Select treatment guidelines
April 20, 2010 ·
Leave a comment
At Thought Leader Select, we employ a proprietary research methodology to identify key opinion leaders (KOLs) for pharmaceutical and biotechnology companies. This methodology, known as deep profiling, enables biopharmaceutical firms to optimize teams of KOLs for different deployment areas throughout the development of new medicines and during the life cycles of their brands.
At the core of our methodology is a belief in the uniqueness of each key opinion leader, whether he or she is a physician, physician assistant, nurse practitioner, pharmacist, veterinarian, or other leader in the health care sector. According to Dr. Max Noureddine, Thought Leader Select’s chief scientific officer, we define key opinion leaders as “the people who leave a footprint in the field.”
“KOLs are the people who make noticeable contributions to the medical field, by advancing science and blazing new paths forward for other scientists in the field,” said Noureddine. “Their achievements in basic and clinical research, clinical investigation, and their treatment of patients have a remarkable impact on others in the field. Quite simply, key opinion leaders are the change agents within the field—they cause fundamental changes in how we look at different diseases and how we can possibly treat them, and others follow their work accordingly.”
KOLs change the course of pharmaceutical discovery and development ... read more »
TAGS: advisory boards basic research biotechnology clinical investigation clinical trials consulting disease states drug development key opinion leaders KOL deployment KOL identification KOL profiling KOL selection KOLs Maher Noureddine medical research pharmaceutical rising star KOLs therapeutic areas
April 15, 2010 ·
1 comment
Dr. Maher “Max” Noureddine joined Thought Leader Select as its chief scientific officer in 2007, after a two-year stint as a senior research fellow in molecular genetics at the National Institute of Environmental Health Sciences/National Institutes of Health (NIEHS/NIH). Prior to his time at the NIEHS/NIH, Max conducted post-doctoral research in Parkinson’s disease at Duke University Medical Center from 2002-2005. In 2002, Max earned a PhD in biology from the University of North Carolina at Chapel Hill. During his career, Max has co-authored 13 published research studies and presented his research findings at 13 conferences.
The Thought Leader Select Blog recently sat down to catch up with Max Noureddine and learn about his background and how he makes his professional contribution to the work of Thought Leader Select.
TLS Blog: Thanks for agreeing to an interview with your busy schedule, Max. Why did you join Thought Leader Select in 2007?
Max: I was at a critical juncture of my career, finishing up my post-doctoral work at Duke in the field of Parkinson’s disease. Basically, I was weighing up my career alternatives, which normally would mean that someone with my academic and scientific background would head straight into university teaching and research.
I had gotten to know Paul Meade, the founder of the company, since we were both pilots in the Civil Air Patrol together. ... read more »
TAGS: aviation biotechnology cancer chief scientific officer Civil Air Patrol clinical research Duke University Medical Center genetics key opinion leader KOL KOL identification KOL profiling Maher Noureddine NIEHS/NIH Parkinson's disease pharmaceutical pilots research methods science Thought Leader Select UNC-Chapel Hill
April 6, 2010 ·
Leave a comment
April 6, 2010 (Chapel Hill, NC)— A new, more robust alternative to influence mapping for sophisticated key opinion leader (KOL) identification and deployment solutions throughout a drug therapy’s life cycle is the rigorous methodology employed by North Carolina firm, Thought Leader Select. Known as “deep profiling,” Thought Leader Select’s objective, validated methods identified 75% of the chosen physicians over influence mapping in a recent comparison commissioned by a top-10 pharmaceutical concern.
The study, which spanned the last two quarters of 2009, compared the custom research, technology and counsel of Thought Leader Select to the more widespread method of influence mapping, which identifies and profiles potential KOLs using more subjective social networking data and physician surveys. For the comparison project, the commissioning pharmaceutical company asked Thought Leader Select to identify 40 key opinion leaders in internal medicine, public health, and infectious disease—doctors who will serve in critical roles in the development of new influenza vaccines.
Thought Leader Select’s methods favor objective research that can be validated by both Thought Leader Select and its clients. While subjective social survey methods have some documented success in identifying leading physicians for drug development work, Thought Leader Select’s more tightly focused results enable pharmaceutical companies to engage the right KOLs for the right tasks at the right time.
The results were remarkable, as the company chose a significantly ... read more »
TAGS: deep-profiling infectious disease influence mapping influenza vaccines internal medicine key opinion leader key opinion leader identification KOL Maher Noureddine Neil Mellor objective research pharmaceutical public health research Thought Leader Select
